Cargando…
Metformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer Cells
SIMPLE SUMMARY: In the present study, we sought to determine whether a commonly used oral drug to treat adult-onset diabetes, metformin, which has a longstanding clinical history and known safety and tolerability profile, can improve the anti-cancer effects of two well-established oral agents curren...
Autores principales: | Xie, Yi, Wang, Linbo, Khan, Mohammad A., Hamburger, Anne W., Guang, Wei, Passaniti, Antonino, Munir, Kashif, Ross, Douglas D., Dean, Michael, Hussain, Arif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914929/ https://www.ncbi.nlm.nih.gov/pubmed/33562646 http://dx.doi.org/10.3390/cancers13040633 |
Ejemplares similares
-
Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells
por: Adediran, Samusi, et al.
Publicado: (2022) -
Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012) -
AB69. Phyto-androgenic androgens in men’s health, sex and aging FX
por: Adimoelja, Arif, et al.
Publicado: (2014) -
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010) -
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
por: Asim, Mohammad, et al.
Publicado: (2017)